Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+HR+ breast cancer after trastuzumab-based therapy on patient outcomes
No Thumbnail Available
Identifiers
Date
2020-05-01
Authors
Martin Jimenez, M.
Gnant, M. I.
Ejlertsen, B.
Mansi, J. L.
Ruiz-Borrego, M.
Jakobsen, E. H.
Osborne, C. K.
Birhiray, R.
Zhang, B.
Wong, A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
